Here, IL6 and HOXA4 were found to be specifically downregulated, and their low expression predicted low RFS in LumB-subtype breast cancer (p < 0.05), and the prognostic analysis result of IL6 was consistent with tha in all breast cancer. The gene discussed is HOXA4; the disease is breast cancer.